文献速递咽喉与嗓音头颈外科

评估诊室喉咽病变内镜活检的准确性、安全性与耐受性

Assessing the Accuracy, Safety, and Tolerance of Office-Based Endoscopic Biopsies for Laryngopharyngeal Lesions.
PubMed 文献 · Laryngoscope · 2025-05-03

该回顾性分析纳入490例使用远端芯片工作通道内镜进行的诊室活检,评估其准确性、安全性与耐受性。结果显示无严重并发症,操作不耐受致4.1%未完成,88.4%的活检指导了处理;对浸润性恶性肿瘤/重度异型增生,敏感度89.4%、特异度95.8%、准确率91.7%。结论认为诊室活检安全、总体耐受良好,在合适临床情境下可提供可靠诊断结果。

要点

  • 490例诊室活检中无严重并发症,4.1%因不耐受未完成。
  • 88.4%的诊室活检指导了临床处理。
  • 对浸润性恶性肿瘤/重度异型增生,敏感度89.4%、准确率91.7%。

核心结论

  • 诊室喉咽病变活检安全、总体耐受良好,在合适临床情境下可提供可靠诊断结果。

研究设计与样本

  • 回顾性分析490例使用远端芯片工作通道内镜进行的诊室活检。
  • 组织学准确性通过与手术室活检比较评估,良性病变则通过随时间监测内镜表现评估。

主要发现

  • 活检部位以声门区喉部(52.4%)、声门上喉部(17.3%)和舌根(14.5%)为主。
  • 操作不耐受致4.1%未完成,其中咽反射17例、喉痉挛3例;无严重并发症报告。
  • 诊室活检指导了88.4%病例的处理。
  • 组织学结果:良性33.3%、癌前病变27.6%、恶性37.6%、标本不足1.5%。
  • 13例(8.3%)初始判为良性和37例(28.5%)癌前病变经进一步活检发现为恶性。

关键数值与推荐

  • 对浸润性恶性肿瘤/重度异型增生,诊室活检敏感度89.4%、特异度95.8%、阳性预测值97.4%、阴性预测值83.4%、准确率91.7%。

临床怎么用

  • 作者认为诊室喉咽病变活检安全、总体耐受良好,在合适临床情境下可提供可靠诊断结果。
  • 作者认为诊室活检发现重度异型增生或原位癌时应怀疑浸润性恶性肿瘤。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The increasing prevalence of office-based biopsies (OBBs) for diagnosing laryngopharyngeal lesions underscores the need for a comprehensive evaluation of their clinical utility. This study aims to investigate the accuracy, safety, and tolerance of these procedures in an office setting. METHODS: We conducted a retrospective analysis of 490 OBBs performed with distal chip, working channel endoscopes. Histologic accuracy was assessed by comparing OBB results with operating room biopsies or, for benign lesions, by monitoring endoscopic findings over time. RESULTS: The majority of OBBs were taken primarily from the glottic larynx (52.4%), supraglottic larynx (17.3%), and base of tongue (14.5%). Procedural intolerance led to noncompletion in 4.1% of cases due to gag reflex (17 cases) and laryngospasm (3 cases); no serious complications were reported. OBBs guided management in 88.4% of cases. Histologically, 33.3% of cases were benign, 27.6% pre-malignant, 37.6% malignant, and 1.5% yielded inadequate specimens. Thirteen lesions (8.3%) initially identified as benign and 37 pre-malignant lesions (28.5%) were found to be malignant upon further biopsy. For invasive malignancies/severe dysplasia, OBBs showed a sensitivity of 89.4%, specificity of 95.8%, positive predictive value of 97.4%, negative predictive value of 83.4%, and accuracy of 91.7%. CONCLUSION: Office-based biopsies of laryngopharyngeal lesions are safe, generally well-tolerated, and offer reliable diagnostic results in appropriate clinical settings. Severe dysplasia or carcinoma in situ identified on OBB should prompt suspicion for invasive malignancy.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Clark A, Nam YS, MacKay C, et al. Assessing the Accuracy, Safety, and Tolerance of Office-Based Endoscopic Biopsies for Laryngopharyngeal Lesions. Laryngoscope. 2025. PMID: 40318034. doi:10.1002/lary.32197

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。